Nanjing 1st Hospital

Nanjing 210006

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Moderately to Severely Active Ulcerative Colitis

Studies at this site

• A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling